Physician

Fahad Syed Gilani, M.D.

According to 2025 Medicare claims, Fahad Gilani, M.D. (NPI: 1184884975) practices cardiology in the Manchester-Nashua, NH market, with the plurality of this provider's patient population coming from Hillsborough, NH. This provider's primary affiliated billing organization is CARDIOVASCULAR SPECIALISTS OF NEW ENGLAND, LLC (NPI: 1992563589; TIN: 991635988) and primary practice location at 03053-3417. Gilani is affiliated with the Aledade 205 New England MSSP Enhanced (ACO ID: A5370), Aledade 201 National MSSP (ACO ID: A5522), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gilani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 544 traditional Medicare patients, billed 1,404 HCPCS/CPT codes, and received $168,140 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 960 prescription claims across 206 beneficiaries totaling $144,034 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 167 records totaling $103,244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $8,875 to $144,034. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	416	679	$70,107
2017	881	1,495	$185,686
2018	796	1,334	$150,734
2019	571	977	$155,918
2020	502	780	$121,253
2021	426	671	$134,697
2022	489	763	$123,158
2023	453	882	$144,693
2024	544	1,404	$168,140

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	45	113	$8,875
2017	112	535	$50,129
2018	131	701	$75,820
2019	124	731	$87,872
2020	136	882	$103,328
2021	147	832	$107,785
2022	147	864	$132,709
2023	148	847	$135,242
2024	206	960	$144,034

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	70	70	$119
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	60	61	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	199	233	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	55	56	$12
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	109	120	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	90	4,924	$89,998
Xarelto	Rivaroxaban	16	1,200	$23,039
Jardiance	Empagliflozin	11	570	$11,208
Metoprolol Succinate	Metoprolol Succinate	190	15,465	$2,006
Torsemide	Torsemide	24	1,333	$1,002

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$74,941	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$28,304	Catholic Medical Center
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fahad Syed Gilani, M.D.?

Tedicare shows public-source Medicare data for Fahad Syed Gilani, M.D. (NPI 1184884975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fahad Syed Gilani, M.D. have ACO affiliation data?

Fahad Syed Gilani, M.D. is shown with ACO affiliation data for Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370), Aledade 201 National MSSP (MSSP, ACO ID A5522), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Fahad Syed Gilani, M.D.?

Fahad Syed Gilani, M.D. is linked to CARDIOVASCULAR SPECIALISTS OF NEW ENGLAND, LLC (billing NPI 1992563589) in the available physician profile data.

Does Fahad Syed Gilani, M.D. have Open Payments data?

Fahad Syed Gilani, M.D. has 167 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.